| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.7213 | 53 |
| GSM780708 | Untreated after 4 days (C2_1) | 50.6065 | 50 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.4155 | 50 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.198 | 42 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.3083 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 53.051 | 56 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.5665 | 57 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.4917 | 39 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 50.9783 | 51 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.823 | 44 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 48.8963 | 45 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.6569 | 57 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.7032 | 53 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.0086 | 17 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.6934 | 26 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 52.0457 | 54 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.5462 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 54.4579 | 59 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.1829 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.5707 | 50 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.4435 | 50 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.5738 | 35 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.1075 | 33 |